BOSTON and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company ...

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

It was anti-tubulin payload. So ... I wonder if you could just update us on your – the confidence in your TIGIT antibody and any points of differentiation that you would cite for that molecule?

Other big financings this week Swiss biotech Alentis Therapeutics raised more than $181 million in a Series D that will support clinical trials of two antibody-drug conjugates (ADCs) targeting ...

Their goal was to create a more powerful antibody treatment against influenza A, one of the most common and deadly strains of the virus. What they discovered could change how people are protected ...

Naturally, the pharma industry has seen an explosion of mAbs in the pipeline, which has led to the evolution of new methods for improving and refining the antibody pipeline. Artificial ...

A new online validation initiative pairs structural and functional insights to help scientists map epitopes in a 3D context, enhancing antibody-based assay efficiency and accuracy. New approaches pair ...

Antibodies against B cells Rituximab is a depleting antibody directed against CD20 on the surface of B cells, which has established benefit in RA both with regards to clinical efficacy and ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...

Siles Alvarado and Schuler et al. examine the long-term dynamics of SARS-CoV-2 antibodies in individuals with varying COVID-19 severities over 12 months. While anti-N antibodies decline, anti-RBD ...

Serum samples from patients with each condition often have anti-GQ1b IgG antibody. METHODS Information on antecedent illness, initial symptoms, neurological signs during the illness, and CSF findings ...